A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

NCT01685203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: ABT-450/r
DRUG: ABT-267
DRUG: Ribavirin (RBV)

Sponsor

AbbVie (prior sponsor, Abbott)